{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:49:06Z","timestamp":1790419746986,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011438","name":"Texas Academy of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012446","name":"Oslo University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["trasci.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.transci.2024.103969","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T06:57:08Z","timestamp":1719903428000},"page":"103969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Why do RhD negative pregnant women still become anti-D immunized despite prophylaxis with anti-D immunoglobulin?"],"prefix":"10.1016","volume":"63","author":[{"given":"\u00c7i\u011fdem Akal\u0131n","family":"Akk\u00f6k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2024.103969_bib1","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1537-2995.2010.03006.x","article-title":"Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME)","volume":"51","author":"Dajak","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103969_bib2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1537-2995.2011.03362.x","article-title":"Report of the first nationally implemented clinical routine screening for fetal RHD in D\u2212 pregnant women to ascertain the requirement for antenatal RhD prophylaxis","volume":"52","author":"Clausen","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103969_bib3","doi-asserted-by":"crossref","first-page":"i5789","DOI":"10.1136\/bmj.i5789","article-title":"Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands","volume":"355","author":"de Haas","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.transci.2024.103969_bib4","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/aogs.13191","article-title":"Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland","volume":"96","author":"Haimila","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.transci.2024.103969_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/tme.12772","article-title":"The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti-D prophylaxis","volume":"31","author":"S\u00f8rensen","year":"2021","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2024.103969_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070984","article-title":"Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program","volume":"8","author":"Tiblad","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.transci.2024.103969_bib7","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/aogs.14261","article-title":"Management and clinical consequences of red blood cell antibodies in pregnancy: a population-based cohort study","volume":"100","author":"Liu","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.transci.2024.103969_bib8","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/1471-0528.17118","article-title":"Risk factors for RhD immunisation in a high coverage prevention programme of antenatal and postnatal RhIg: a nationwide cohort study","volume":"129","author":"Slootweg","year":"2022","journal-title":"BJOG"},{"key":"10.1016\/j.transci.2024.103969_bib9","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/aogs.14216","article-title":"Time points and risk factors for RhD immunizations after the implementation of targeted routine antenatal anti-D prophylaxis: a retrospective nationwide cohort study","volume":"100","author":"Jernman","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.transci.2024.103969_bib10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/1471-0528.12175","article-title":"Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme","volume":"120","author":"Bolton-Maggs","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.transci.2024.103969_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12884-022-05329-z","article-title":"Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape","volume":"23","author":"de Winter","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.transci.2024.103969_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/uog.17319","article-title":"Complications of intrauterine intravascular blood transfusions: lessons learned after 1678 procedures: IUT complications","volume":"50","author":"Zwiers","year":"2017","journal-title":"Ultrasound Obs Gynecol"},{"key":"10.1016\/j.transci.2024.103969_bib13","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/trf.12484","article-title":"Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis","volume":"54","author":"Kumpel","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103969_bib14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000531694","article-title":"Terminating routine cord blood RhD typing of the newborns to guide postnatal anti-D immunoglobulin prophylaxis based on the results of fetal RHD genotyping","volume":"50","author":"Stensrud","year":"2023","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.transci.2024.103969_bib15","series-title":"Transfusion Statistics 2021","author":"Hoang","year":"2022"},{"key":"10.1016\/j.transci.2024.103969_bib16","unstructured":"Narayan SPD et al. H of T (SHOT) SG. The 2022 Annual SHOT Report. 2023."},{"key":"10.1016\/j.transci.2024.103969_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/tme.12299","article-title":"Guideline for blood grouping and red cell antibody testing in pregnancy","volume":"26","author":"White","year":"2016","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2024.103969_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2014.02.008","article-title":"Noninvasive fetal RhD genotyping","author":"Clausen","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2024.103969_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/vox.13348","article-title":"Single-exon approach to non-invasive fetal RHD screening in early pregnancy: an update after 10\u202fyears\u2019 experience","author":"Uzunel","year":"2022","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2024.103969_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000446816","article-title":"Anti-D antibodies in pregnant D variant antigen carriers initially typed as RhD.","volume":"43","author":"Lukacevic Krstic","year":"2016","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.transci.2024.103969_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/trf.12941","article-title":"It\u2019s time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group","volume":"55","author":"Sandler","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103969_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.21307\/immunohematology-2019-681","article-title":"Detection of anti-D following antepartum injections of Rh immune globulin","volume":"14","author":"Kennedy","year":"1998","journal-title":"Immunohematology"},{"key":"10.1016\/j.transci.2024.103969_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24323","article-title":"Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti-D was incorrectly identified as RhIG","volume":"36","author":"Walhof","year":"2022","journal-title":"J Clin Lab Anal"},{"issue":"3","key":"10.1016\/j.transci.2024.103969_bib25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.21307\/immunohematology-2019-055","article-title":"Laboratory management of perinatal patients with apparently \u201cnew\u201d anti-D","volume":"32","author":"Hannon Judith","year":"2016","journal-title":"Immunohematology"},{"key":"10.1016\/j.transci.2024.103969_bib27","unstructured":"Rhesonativ Injeksjonsv\u00e6ske 625 IE\/ml: 1 ampulle 2 ml, 1250 IE (250 mikrog) 2021. \u3008https:\/\/www.felleskatalogen.no\/medisin\/rhesonativ-octapharma-563447\u3009 (accessed January 7, 2024)."},{"key":"10.1016\/j.transci.2024.103969_bib28","unstructured":"Tiller, Heidi; Haugen Guttorm; Bakken, Knut; Akk\u00f6k \u00c7.A. Norwegian National Guidelines for Obstetrics- RBC alloimmunization. 2021, Updat 2023 2021. \u3008https:\/\/www.legeforeningen.no\/foreningsledd\/fagmed\/norsk-gynekologisk-forening\/veiledere\/veileder-i-fodselshjelp\/alloimmunisering-mot-erytrocytt-antigener\/\u3009."},{"key":"10.1016\/j.transci.2024.103969_bib29","first-page":"1","article-title":"Determination of fetal RHD type in plasma of RhD negative pregnant women","author":"S\u00f8rensen","year":"2018","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.transci.2024.103969_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/tme.12091","article-title":"BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn","volume":"24","author":"Qureshi","year":"2014","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2024.103969_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IJWH.S390661","article-title":"Management of wrong blood transfusion to an RhD negative woman in labor","volume":"15","author":"Titze","year":"2023","journal-title":"Int J Women\u2019s Health"},{"key":"10.1016\/j.transci.2024.103969_bib32","unstructured":"National guidelines for transfusion medicine services in Norway. 2017. \u3008https:\/\/helsedirektoratet.no\/retningslinjer\/veileder-for-transfusjonstjenesten-i-norge\u3009 (accessed September 2, 2022)."},{"key":"10.1016\/j.transci.2024.103969_bib33","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/bjh.13158","article-title":"Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study","volume":"168","author":"Cid","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2024.103969_bib34","first-page":"s147","article-title":"Red blood cell alloimmunisation after platelet transfusion: a 5-year study","volume":"12 Suppl 1","author":"Moncharmont","year":"2014","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2024.103969_bib35","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/trf.12341","article-title":"Anti-D alloimmunization after D-incompatible platelet transfusions: a 14-year single-institution retrospective review","volume":"54","author":"O\u2019Brien","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2024.103969_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000488804","article-title":"Anti-D alloimmunization after RhD-positive platelet transfusion in RhD-negative women under 55 years diagnosed with acute leukemia: results of a retrospective study","volume":"45","author":"Villalba","year":"2018","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.transci.2024.103969_bib37","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/vox.13092","article-title":"Altered strategy of prophylactic anti-D administration in pregnancy to cover term and post-term - a pilot study","volume":"116","author":"Wikman","year":"2021","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2024.103969_bib38","article-title":"Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: a network meta-analysis","volume":"15","author":"Xie","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.transci.2024.103969_bib39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/aogs.14328","article-title":"Following targeted routine antenatal anti-D prophylaxis, almost half of the pregnant women had undetectable anti-D prophylaxis at delivery","volume":"101","author":"S\u00f8rensen","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.transci.2024.103969_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-3148.2011.01106.x","article-title":"Routine antenatal anti-D prophylaxis--is the protection adequate?","volume":"21","author":"Davies","year":"2011","journal-title":"Transfus Med"},{"key":"10.1016\/j.transci.2024.103969_bib41","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1471-0528.2009.02244.x","article-title":"Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis","volume":"116","author":"Koelewijn","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.transci.2024.103969_bib42","author":"Austin","year":"2011","journal-title":"Guidel Estim Fetomaternal Haemorrhage Lond"},{"key":"10.1016\/j.transci.2024.103969_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/vox.12768","article-title":"Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis\u2013an external quality assessment workshop","volume":"114","author":"Clausen","year":"2019","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2024.103969_bib44","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/vox.12908","article-title":"External quality assessment of noninvasive fetal RHD genotyping","volume":"115","author":"Clausen","year":"2020","journal-title":"Vox Sang"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022400140X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147305022400140X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T17:15:55Z","timestamp":1728321355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147305022400140X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S147305022400140X"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2024.103969","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why do RhD negative pregnant women still become anti-D immunized despite prophylaxis with anti-D immunoglobulin?","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2024.103969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103969"}}